Anika Therapeutics, Inc. (ANIK)
14.64
+0.04
(+0.27%)
USD |
NASDAQ |
Jun 09, 16:00
14.64
0.00 (0.00%)
After-Hours: 16:48
Anika Therapeutics EPS Diluted (Quarterly) : -0.3737 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AbbVie, Inc. | 0.3861 |
| Biogen, Inc. | 2.153 |
| MiMedx Group, Inc. | -0.0732 |
| Agios Pharmaceuticals, Inc. | -1.686 |
| Elutia, Inc. | -0.1836 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.056M |
| Revenue (Quarterly) | 29.61M |
| Total Expenses (Quarterly) | 34.67M |
| Enterprise Value | 179.73M |
| Gross Profit Margin (Quarterly) | 64.15% |
| Profit Margin (Quarterly) | -17.07% |
| Earnings Yield | -5.41% |
| Normalized Earnings Yield | -5.408 |